Author: Athos Therapeutics

Posted Date:

January 26, 2026

Athos Therapeutics Receives US FDA Authorization to Begin Multi-Center Phase 2 Clinical Trial of ATH-063 in Patients with Ulcerative Colitis

Athos Therapeutics

January 26, 2026